What does a ceruloplasmin level of 19 mg/dL indicate in a patient with transaminitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Does a Ceruloplasmin of 19 mg/dL Mean in Transaminitis?

A ceruloplasmin level of 19 mg/dL in a patient with transaminitis is modestly subnormal and requires further evaluation for Wilson disease, though it does not definitively confirm or exclude the diagnosis. 1

Interpretation of This Specific Value

  • Your patient's ceruloplasmin of 19 mg/dL falls just below the normal threshold of 20 mg/dL, placing them in a diagnostic gray zone that demands additional workup 1, 2

  • This level is NOT extremely low (which would be <5 mg/dL), so it does not provide strong evidence for Wilson disease on its own 1, 3

  • Approximately 10-20% of Wilson disease patients actually have ceruloplasmin levels in the normal range (≥20 mg/dL), and conversely, about 20% of heterozygous carriers have decreased levels, creating significant diagnostic overlap 1

Critical Next Steps You Must Take

Calculate the non-ceruloplasmin bound (free) copper immediately:

  • Formula: Serum copper (μg/dL) - [3 × ceruloplasmin (mg/dL)] 1, 4
  • For your patient: Serum copper - [3 × 19] = Serum copper - 57
  • Free copper >25 μg/dL suggests Wilson disease 1, 4

Obtain 24-hour urinary copper excretion:

  • >100 μg/24 hours strongly indicates Wilson disease 4
  • Normal is typically <40 μg/24 hours 1

Arrange slit-lamp examination for Kayser-Fleischer rings:

  • Their presence strongly supports Wilson disease, though absence does not exclude it (especially in purely hepatic presentations) 1, 4

Consider liver biopsy with quantitative copper measurement:

  • Hepatic copper >250 μg/g dry weight confirms Wilson disease 2

Common Pitfalls to Avoid

Do not assume this borderline low ceruloplasmin automatically means Wilson disease:

  • In one screening study of 2,867 patients with liver disease, only 5.9% of those with ceruloplasmin <20 mg/dL actually had Wilson disease 5
  • The positive predictive value of low ceruloplasmin alone is only 11.1% in unselected populations 6

Other causes of modestly low ceruloplasmin in the setting of transaminitis include:

  • Heterozygous carrier status for Wilson disease (20% have low levels) 1
  • Severe end-stage liver disease from any cause 3
  • Protein-losing conditions 3
  • Copper deficiency 3
  • Alcoholic liver disease (can decrease ceruloplasmin activity) 7

Do not be falsely reassured by this "almost normal" value:

  • Up to 22% of confirmed Wilson disease patients had ceruloplasmin ≥17 mg/dL in published series 1
  • In pediatric Wilson disease, 10 of 28 children had ceruloplasmin ≥20 mg/dL 1

Why This Matters for Morbidity and Mortality

Missing Wilson disease has catastrophic consequences:

  • Untreated Wilson disease progresses to cirrhosis, neurological degeneration, and death 2
  • Early treatment with chelation therapy (D-penicillamine or trientine) can prevent disease progression and prolong life indefinitely 3, 2

The diagnostic workup must be completed even with this borderline value because the stakes of missing Wilson disease far outweigh the cost and inconvenience of additional testing 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Low Ceruloplasmin (Hypoceruloplasminemia)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hypercupremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.